Asthma in children: Are chlamydia or mycoplasma involved?

Paediatric Drugs

Volumn 3, Issue 3, 2001, Pages 159-168

  Esposito, S ^a   Principi, N ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; BRONCHODILATING AGENT; CLARITHROMYCIN; CORTICOSTEROID; DOXYCYCLINE; ERYTHROMYCIN; MACROLIDE; TETRACYCLINE DERIVATIVE;

ADOLESCENT; AIR POLLUTION; ASTHMA; CHILD; CHLAMYDOPHILA PNEUMONIAE; CHRONICITY; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG INDICATION; GENETIC SUSCEPTIBILITY; HUMAN; MYCOPLASMA PNEUMONIAE; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; RISK FACTOR; SMOKING; SYMPTOM; WHEEZING;

EID: 0035087186     PISSN: 11745878     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128072-200103030-00001     Document Type: Review

References (77)

1. Changing patterns of asthma mortality: Identifying target populations at high risk
2. Wheezing disorders in infancy
3. Risk factors for early, persistent, and late-onset wheezing in young children
4. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema
5. Is asthma increasing?
6. ISAAC: A hypothesis generator for asthma?
7. Asthma in children
8. Asthma: Past, present and future
9. Risk factors for acute wheezing in infants and children: Viruses, passive smoke, and IgE antibodies to inhalant allergens
10. The relationships among environmental allergen sensitization, allergen exposure, pulmonary function, and bronchial hyperresponsiveness in the childhood asthma management program
11. Family size, atopic disorders in parents, asthma in children, and ethnicity
12. Clinical applications of cytokines: New directions in the therapy of atopic disease
13. Immunologic basis of chronic allergic diseases: Clinical messages from the laboratory bench
14. Clinical features and their assessment
15. Types of asthma and wheezing
16. Asthma and wheezing in the first six years of life
17. Wheezing in school children is not always asthma
18. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: A prospective cohort study with matched controls
19. Interleukin-4, soluble CD23 and interferon gamma levels in serum during the first 18 months of life
20. Viral infections and the development of asthma
21. Infectious asthma: A reemerging clinical entity?
22. Acute asthma epidemics, weather and pollen in England, 1987-1994
23. Role and contribution of viral respiratory infections to asthma
24. Atypical pneumonias in children
25. Two family outbreaks of chlamydia pneumoniae infection
26. Incidence of upper respiratory tract mycoplasma pneumoniae infections among outpatients in Rhone-Alpes, France, during five successive winter periods
27. The role of atypical pathogens: Mycoplasma pneumoniae, chlamydia pneumoniae, and legionella pneumophila in respiratory infection
28. Chlamydia pneumoniae in children with acute respiratory tract infections
29. Association of chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma
30. Mycoplasma pneumoniae disease: Clinical spectrum, pathophysiology, epidemiology, and control
31. Chlamydia pneumoniae, asthma, and COPD: What is the evidence?
32. Pathogenetic mechanisms and epidemiology of chlamydia pneumoniae
33. Interaction of chlamydia pneumoniae and human alveolar macrophages: Infection and inflammatory response
34. Chlamydia pneumoniae (TWAR) infections in children
35. Detection of mycoplasma pneumoniae by two polymerase chain reactions and role of M. pneumoniae in acute respiratory tract infections in pediatric patients
36. Mycoplasma pneumoniae and chlamydia pneumoniae in pediatric community-acquired pneumonia: Comparative efficacy and safety of clarithromycin vs erythromycin ethylsuccinate
37. Lower respiratory tract infections in children: Role of atypical pathogens
38. Comparative tolerability of erythromycin and newer macrolide antibacterials in paediatric patients
39. Susceptibilities to clarithromycin and erythromycin of isolates of chlamydia pneumoniae from children with pneumonia
40. Antibiotic susceptibilities of mycoplasmas and treatment of mycoplasmal infections
41. Acute exacerbations of asthma in adults: Role of chlamydia pneumoniae infection
42. Chlamydia pneumoniae infection in Italian patients
43. The results of pulmonary function tests in patients infected with mycoplasma pneumoniae
44. Association of viral and mycoplasma infections with exacerbations of asthma
45. Mycoplasma pneumoniae is a frequent cause of exacerbation of bronchial asthma in adults
46. The association of viral and mycoplasma infections with recurrence of wheezing in the asthmatic child
47. IgE antibodies to mycoplasma pneumoniae in asthma and other atopic disease
48. Isolation of mycoplasma pneumoniae from asthmatic patients
49. Detection of mycoplasma pneumoniae in the airways of adults with chronic asthma
50. Mycoplasma and chlamydia are present in the airways of chronic, stable asthmatics
51. The association of chlamydia pneumoniae infection and reactive airway disease in children
52. Chronic chlamydia pneumoniae infection and asthma exacerbations in children
53. Influence of viral and bacterial respiratory infections on exacerbations and symptom severity in childhood asthma
54. Polymerase chain reaction for detection of chlamydia pneumoniae in gargled-water specimens of children
55. Detection of antichlamydia pneumoniae IgE in children with reactive airway disease
56. Chlamydia pneumoniae, mycoplasma pneumoniae and mycoplasma fermentans PCR in children with acute respiratory tract infections
57. Chlamydia pneumoniae infection in patients with cystic fibrosis
58. Importance of mycoplasma pneumoniae and chlamydia pneumoniae acute infection in children with recurrent wheezing
59. Detection of viral, chlamydia pneumoniae and mycoplasma pneumoniae infections in exacerbations of asthma in children
60. Mycoplasma pneumoniae: Acute illness, antibiotics, and subsequent pulmonary function
61. Mycoplasma pneumoniae infection: A follow-up study of 50 children with respiratory illness
62. Clinical observations on lower respiratory tract infections with special reference to serum IgE levels
63. Chlamydia pneumoniae (TWAR) infection in Tanzanian children
64. Chlamydia pneumoniae in children attending day-care-centers in Gavle, Sweden
65. Treatment of chlamydia pneumoniae infection in adult asthma: A before-after trial
66. Evidence for chlamydia pneumoniae infection in steroid-dependent asthma
67. Mycoplasma and chlamydia cause increased airway inflammation that is responsive to clarithromycin
68. Association between intracellular pathogen infection and wheezing in children
69. Persistent infection with chlamydia pneumoniae following acute respiratory illness
70. Etiology and response to antibiotic therapy of community-acquired pneumonia in French children
71. Anti-inflammatory effects of macrolide antibiotics
72. Comparative anti-inflammatory effects of roxithromycin, azithromycin and clarithromycin
73. The anti-inflammatory effects of macrolides
74. Laboratory diagnosis of respiratory infections
75. Etiology of childhood pneumonia: Serologic results of a prospective, population-based study
76. Relevance of nucleic acid amplification techniques for diagnosis of respiratory tract infections in the clinical laboratory